KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 1

The Assessment of Resistant Hypertension-Related Cardiovascular Risk

Bilgin Bahadır BAŞGÖZ
Tolga DOĞAN
Musa Barış AYKAN
Suat GÖRMEL
Kenan SAĞLAM
Mehmet ERSEN
Sayfa
128–135
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There were no significant differences between the groups in resistant andregular hypertension (HTN) and also dipping and non-dipping groups in RH in terms of other parameters.Conclusion: Significant differences were detected between RH and regulated HTN patients in terms of CIMT and microalbuminuria, but there was no difference between the dipping and non-dipping groups in terms of atheroscleroticburden.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The effect of resistant hypertension (RH) on cardiovascular risk has not been clarified.
📊
Temel Bulgular & Veri:RH patients were divided intodipping and non-dipping groups according to the ABPM and the comparison of end-organ damage among themselveswas performed separately.Results: A total of 95 patients were enrolled, 61 in RH group.
💡
Sonuç & Katkı:There were no significant differences between the groups in resistant andregular hypertension (HTN) and also dipping and non-dipping groups in RH in terms of other parameters.Conclusion: Significant differences were detected between RH and regulated HTN patients in terms of CIMT and microalbuminuria, but there was no difference between the dipping and non-dipping groups in terms of atheroscleroticburden.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: The effect of resistant hypertension (RH) on cardiovascular risk has not been clarified. According to the ambulatory blood pressure monitoring (ABPM) results, cardiovascular disease outcomes are more common in patients withnon-dipping pattern. We aimed to show cardiac end-organ damages in RH and non-dipping patients within the RH.Methods: RH and regular hypertensive cases were included. Cardiovascular endpoints were determined as carotidintima-media thickness (CIMT), echocardiography parameters, and microalbuminuria. RH patients were divided intodipping and non-dipping groups according to the ABPM and the comparison of end-organ damage among themselveswas performed separately.Results: A total of 95 patients were enrolled, 61 in RH group. Significant differences were found between the RH andthe regular hypertensive group in terms of CIMT and microalbuminuria (p=0.020 for the right CIMT, p=0.016 for the leftCIMT, and p=0.003 for the microalbuminuria). There were no significant differences between the groups in resistant andregular hypertension (HTN) and also dipping and non-dipping groups in RH in terms of other parameters.Conclusion: Significant differences were detected between RH and regulated HTN patients in terms of CIMT and microalbuminuria, but there was no difference between the dipping and non-dipping groups in terms of atheroscleroticburden.

🔖

Bu Makaleye Atıf Yap

BAŞGÖZ, B. B., DOĞAN, T., AYKAN, M. B., GÖRMEL, S., SAĞLAM, K., ERSEN, M. (2022). The Assessment of Resistant Hypertension-Related Cardiovascular Risk. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 1, 128–135. https://ajindex.com/articles/650387

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Achelrod D, Wenzel U, Frey S. Systematic review and metaanalysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens 2015;28:355–61
  2. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011;57:1076–80
  3. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:1269–324
  4. Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: Detection, evaluation, and management: A scientific statement from the american heart association. Hypertension 2018;72:e53–90
  5. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006;354:2368–74
  6. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007;115:2145–52
  7. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy lifeyears lost, and age-specific associations in 1 25 million people. Lancet 2014;383:1899–911
  8. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: The ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2010;55:1600–7
  9. Bombelli M, Facchetti R, Cuspidi C, Villa P, Dozio D, Brambilla G, et al. Prognostic significance of left atrial enlargement in a general population: Results of the PAMELA study. Hypertension 2014;64:1205–11
  10. De Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010;56:99–104
  11. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1–266
  12. Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cífková